Update on Thalassemia: Clinical Care and Complications

Pediatric Clinics of North America

Volumn 55, Issue 2, 2008, Pages 447-460

  Cunningham, Melody J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; ALPHA INTERFERON; BETA GLOBIN; DEFEROXAMINE; HEPATITIS B VACCINE; RIBAVIRIN;

ALLOIMMUNIZATION; ALPHA THALASSEMIA; ANEMIA; BETA THALASSEMIA; BONE MARROW TRANSPLANTATION; CHROMOSOME 11; CHROMOSOME 16; CONTINUOUS INFUSION; ERYTHROCYTE TRANSFUSION; GENE MUTATION; GENE THERAPY; GLOBIN GENE; HEMOLYSIS; HEPATITIS B; HEPATITIS C; HUMAN; IRON OVERLOAD; MALARIA; MORBIDITY; PATHOPHYSIOLOGY; REVIEW; SPLENOMEGALY; THALASSEMIA MAJOR; THROMBOSIS; UNITED STATES; VIRUS INFECTION;

BETA-THALASSEMIA; BONE MARROW TRANSPLANTATION; CHILD; GENE THERAPY; HUMANS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 41149154961     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2008.02.002     Document Type: Review

References (75)

1. Weatherall D.J., and Clegg J.B. Historical perspectives: the many and diverse routes to our current understanding of the thalassaemias. In: Weatherall D.J., and Clegg J.B. (Eds). The thalassaemia syndromes. 4th edition (2001), Blackwell Science, Oxford (England) 3-62
2. Deisseroth A., Nienhuis A., Turner P., et al. Localization of the human alpha-globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay. Cell 12 1 (1977) 205-218
3. Deisseroth A., Nienhuis A., Lawrence J., et al. Chromosomal localization of human beta globin gene on human chromosome 11 in somatic cell hybrids. Proc Natl Acad Sci U S A 75 3 (1978) 1456-1460
4. Cunningham M.J., Macklin E.A., Neufeld E.J., et al. Complications of beta-thalassemia major in North America. Blood 104 1 (2004) 34-39
5. Cao A. Carrier screening and genetic counselling in beta-thalassemia. Int J Hematol 76 Suppl 2 (2002) 105-113
6. Galanello R., Sanna M.A., Maccioni L., et al. Fetal hydrops in Sardinia: implications for genetic counselling. Clin Genet 38 5 (1990) 327-331
7. Calleja E.M., Shen J.Y., Lesser M., et al. Survival and morbidity in transfusion-dependent thalassemic patients on subcutaneous desferrioxamine chelation. Nearly two decades of experience. Ann N Y Acad Sci 850 (1998) 469-470
8. Mohammadian S., Bazrafshan H.R., and Sadeghi-Nejad A. Endocrine gland abnormalities in thalassemia major: a brief review. J Pediatr Endocrinol Metab 16 7 (2003) 957-964
9. Borgna-Pignatti C., Cappellini M.D., De S.P., et al. Survival and complications in thalassemia. Ann N Y Acad Sci 1054 (2005) 40-47
10. Olivieri N.F., Nathan D.G., MacMillan J.H., et al. Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 331 9 (1994) 574-578
11. Clegg J.B., and Weatherall D.J. Thalassemia and malaria: new insights into an old problem. Proc Assoc Am Physicians 111 4 (1999) 278-282
12. Weatherall D.J. Thalassaemia and malaria, revisited. Ann Trop Med Parasitol 91 7 (1997) 885-890
13. Flint J., Hill A.V., Bowden D.K., et al. High frequencies of alpha-thalassaemia are the result of natural selection by malaria. Nature 321 6072 (1986) 744-750
14. Kanavakis E., Tzotzos S., Liapaki K., et al. Molecular basis and prevalence of alpha-thalassemia in Greece. Birth Defects Orig Artic Ser 23 5B (1988) 377-380
15. Falusi A.G., Esan G.J., Ayyub H., et al. Alpha-thalassaemia in Nigeria: its interaction with sickle-cell disease. Eur J Haematol 38 4 (1987) 370-375
16. Vichinsky E.P. Changing patterns of thalassemia worldwide. Ann N Y Acad Sci 1054 (2005) 18-24
17. Vichinsky E.P., Macklin E.A., Waye J.S., et al. Changes in the epidemiology of thalassemia in North America: a new minority disease. Pediatrics 116 6 (2005) e818-e825
18. Lorey F., Cunningham G., Vichinsky E.P., et al. Universal newborn screening for Hb H disease in California. Genet Test 5 2 (2001) 93-100
19. Logothetis J., Economidou J., Constantoulakis M., et al. Cephalofacial deformities in thalassemia major (Cooley's anemia). A correlative study among 138 cases. Am J Dis Child 121 4 (1971) 300-306
20. Kearney S.L., Nemeth E., Neufeld E.J., et al. Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer 48 1 (2007) 57-63
21. Detivaud L., Nemeth E., Boudjema K., et al. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood 106 2 (2005) 746-748
22. Gardenghi S., Marongiu M.F., Ramos P., et al. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 109 11 (2007) 5027-5035
23. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102 3 (2003) 783-788
24. Weinstein D.A., Roy C.N., Fleming M.D., et al. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100 10 (2002) 3776-3781
25. Breda L., Gardenghi S., Guy E., et al. Exploring the role of hepcidin, an antimicrobial and iron regulatory peptide, in increased iron absorption in beta-thalassemia. Ann N Y Acad Sci 1054 (2005) 417-422
26. De F.L., Daraio F., Filippini A., et al. Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia. Haematologica 91 10 (2006) 1336-1342
27. Porter J.B., Abeysinghe R.D., Marshall L., et al. Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. Blood 88 2 (1996) 705-713
28. Borgna-Pignatti C., Rugolotto S., De S.P., et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89 10 (2004) 1187-1193
29. Aghai E., Shabbad E., Quitt M., et al. Discrimination between iron deficiency and heterozygous beta-thalassemia in children. Am J Clin Pathol 85 6 (1986) 710-712
30. Lie-Injo L.E., and Jo B.H. A fast-moving haemoglobin in hydrops foetalis. Nature 185 (1960) 698
31. Kan Y.W., Allen A., and Lowenstein L. Hydrops fetalis with alpha thalassemia. N Engl J Med 276 1 (1967) 18-23
32. Ehlers K.H., Giardina P.J., Lesser M.L., et al. Prolonged survival in patients with beta-thalassemia major treated with deferoxamine. J Pediatr 118 4 Pt 1 (1991) 540-545
33. Karagiorga-Lagana M. Fertility in thalassemia: the Greek experience. J Pediatr Endocrinol Metab 11 Suppl 3 (1998) 945-951
34. Skordis N., Petrikkos L., Toumba M., et al. Update on fertility in thalassaemia major. Pediatr Endocrinol Rev 2 Suppl 2 (2004) 296-302
35. Skordis N., Christou S., Koliou M., et al. Fertility in female patients with thalassemia. J Pediatr Endocrinol Metab 11 Suppl 3 (1998) 935-943
36. Pafumi C., Farina M., Pernicone G., et al. At term pregnancies in transfusion-dependent beta-thalassemic women. Clin Exp Obstet Gynecol 27 3-4 (2000) 185-187
37. Hmida S., Mojaat N., Maamar M., et al. Red cell alloantibodies in patients with haemoglobinopathies. Nouv Rev Fr Hematol 36 5 (1994) 363-366
38. Olujohungbe A., Hambleton I., Stephens L., et al. Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol 113 3 (2001) 661-665
39. Economidou J., Constantoulakis M., Augoustaki O., et al. Frequency of antibodies to various antigenic determinants in polytransfused patients with homozygous thalassaemia in Greece. Vox Sang 20 3 (1971) 252-258
40. Wang L.Y., Liang D.C., Liu H.C., et al. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. Transfus Med 16 3 (2006) 200-203
41. Vichinsky E.P., Earles A., Johnson R.A., et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 322 23 (1990) 1617-1621
42. Singer S.T., Wu V., Mignacca R., et al. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent. Blood 96 10 (2000) 3369-3373
43. Moroni G.A., Piacentini G., Terzoli S., et al. Hepatitis B or non-A, non-B virus infection in multitransfused thalassaemic patients. Arch Dis Child 59 12 (1984) 1127-1130
44. Allain J.P., Thomas I., and Sauleda S. Nucleic acid testing for emerging viral infections. Transfus Med 12 4 (2002) 275-283
45. O'Brien S.F., Yi Q.L., Fan W., et al. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 47 2 (2007) 316-325
46. Ansar M.M., and Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepat 9 5 (2002) 390-392
47. Butensky E., Pakbaz Z., Foote D., et al. Treatment of hepatitis C virus infection in thalassemia. Ann N Y Acad Sci 1054 (2005) 290-299
48. Inati A., Taher A., Ghorra S., et al. Efficacy and tolerability of peginterferon alpha-2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection. Br J Haematol 130 4 (2005) 644-646
49. Telfer P.T., Garson J.A., Whitby K., et al. Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients. Br J Haematol 98 4 (1997) 850-855
50. Wonke B., Hoffbrand A.V., Bouloux P., et al. New approaches to the management of hepatitis and endocrine disorders in Cooley's anemia. Ann N Y Acad Sci 850 (1998) 232-241
51. Borgna-Pignatti C., Vergine G., Lombardo T., et al. Hepatocellular carcinoma in the thalassaemia syndromes. Br J Haematol 124 1 (2004) 114-117
52. Ren F.Y., Piao X.X., and Jin A.L. Efficacy of ultrasonography and alpha-fetoprotein on early detection of hepatocellular carcinoma. World J Gastroenterol 12 29 (2006) 4656-4659
53. Borgna P.C., Carnelli V., Caruso V., et al. Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol 99 2 (1998) 76-79
54. Cappellini M.D. Coagulation in the pathophysiology of hemolytic anemias. Hematology Am Soc Hematol Educ Program 2007 (2007) 74-78
55. Eldor A., and Rachmilewitz E.A. The hypercoagulable state in thalassemia. Blood 99 1 (2002) 36-43
56. Borenstain-Ben Y.V., Barenholz Y., Hy-Am E., et al. Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol 44 1 (1993) 63-65
57. Eldor A., Krausz Y., Atlan H., et al. Platelet survival in patients with beta-thalassemia. Am J Hematol 32 2 (1989) 94-99
58. Reiter C.D., and Gladwin M.T. An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Curr Opin Hematol 10 2 (2003) 99-107
59. Machado R.F., Martyr S., Kato G.J., et al. Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension. Br J Haematol 130 3 (2005) 445-453
60. Pearson H.A., Rink L., and Guiliotis D.K. Thalassemia major in Connecticut: a 20-year study of changing age distribution and survival. Conn Med 85 5 (1994) 259-260
61. Pearson H.A., Guiliotis D.K., Rink L., et al. Patient age distribution in thalassemia major: changes from 1973 to 1985. Pediatrics 80 1 (1987) 53-57
62. Thomas E.D., Buckner C.D., Sanders J.E., et al. Marrow transplantation for thalassaemia. Lancet 2 8292 (1982) 227-229
63. Hongeng S., Pakakasama S., Chuansumrit A., et al. Reduced intensity stem cell transplantation for treatment of class 3 Lucarelli severe thalassemia patients. Am J Hematol 82 12 (2007) 1095-1098
64. La N.G., Argiolu F., Giardini C., et al. Unrelated bone marrow transplantation for beta-thalassemia patients: the experience of the Italian Bone Marrow Transplant Group. Ann N Y Acad Sci 1054 (2005) 186-195
65. Lucarelli G., Galimberti M., Polchi P., et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med 322 7 (1990) 417-421
66. Sodani P., Gaziev D., Polchi P., et al. New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood 104 4 (2004) 1201-1203
67. Lucarelli G., Andreani M., and Angelucci E. The cure of the thalassemia with bone marrow transplantation. Bone Marrow Transplant 28 Suppl 1 (2001) S11-S13
68. Walters M.C., Quirolo L., Trachtenberg E.T., et al. Sibling donor cord blood transplantation for thalassemia major: experience of the Sibling Donor Cord Blood Program. Ann N Y Acad Sci 1054 (2005) 206-213
69. Bhatia M., and Walters M.C. Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. Bone Marrow Transplant 41 2 (2008) 109-117
70. Adamkiewicz T.V., Szabolcs P., Haight A., et al. Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience. Pediatr Transplant 11 6 (2007) 641-644
71. Adamkiewicz T.V., Boyer M.W., Bray R., et al. Identification of unrelated cord blood units for hematopoietic stem cell transplantation in children with sickle cell disease. J Pediatr Hematol Oncol 28 1 (2006) 29-32
72. Walters M.C. Cord blood transplantation for sickle cell anemia: bust or boom?. Pediatr Transplant 11 6 (2007) 582-583
73. Nishino T., Tubb J., and Emery D.W. Partial correction of murine beta-thalassemia with a gammaretrovirus vector for human gamma-globin. Blood Cells Mol Dis 37 1 (2006) 1-7
74. Rivella S., May C., Chadburn A., et al. A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer. Blood 101 8 (2003) 2932-2939
75. Sadelain M., Lisowski L., Samakoglu S., et al. Progress toward the genetic treatment of the beta-thalassemias. Ann N Y Acad Sci 1054 (2005) 78-91